Trial intelligence / Profile preview

Digoxin in peritoneal dialysis-associated pulmonary hypertension

ChiCTR1900023017Phase 4Not yet recruiting

Sponsor
Xiangya Hospital, Central South University
Start
Aug 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of digoxin in pulmonary hypertension (PH), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Pulmonary artery pressure. Planned start Aug 2019; status: not yet recruiting.

02

Drugs

digoxin
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on ChiCTR1900023017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900023017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call